Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
58.88
-1.11 (-1.85%)
Sep 30, 2026, 4:00 PM EDT - Market closed
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $5.55 billion as of September 30, 2026. Its market cap has increased by 159.00% in one year.
Market Cap
5.55B
Enterprise Value
5.68B
1-Year Change
159.00%
Ranking
Category
Stock Price
$58.88
ChartMarket Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $5.55B, an increase of 13,637.85%. That is a compound annual growth rate of 43.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 5.55B | 62.35% |
| Dec 31, 2025 | 3.42B | 151.45% |
| Dec 31, 2024 | 1.36B | 101.24% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 6.01B |
| CG Oncology | 5.95B |
| Scholar Rock Holding | 5.92B |
| Mirum Pharmaceuticals | 5.82B |
| Cogent Biosciences | 5.61B |
| Oruka Therapeutics | 5.59B |
| CRISPR Therapeutics AG | 5.24B |
| PTC Therapeutics | 5.23B |